These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 8339736

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The possible use of radioiodinated metaiodobenzylguanidine (MIBG) in medullary thyroid carcinoma.
    Troncone L, Rufini V, Maussier ML, Valenza V, Montemaggi P, Legnaioli M.
    Thyroidology; 1988 Apr; (1):45-53. PubMed ID: 2484894
    [Abstract] [Full Text] [Related]

  • 8. Detection of medullary carcinoma of the thyroid with I-131 MIBG.
    Thomas CC, Cowan RJ, Albertson DA, Cooper MR.
    Clin Nucl Med; 1994 Dec; 19(12):1066-8. PubMed ID: 7874804
    [Abstract] [Full Text] [Related]

  • 9. Iodine 131 metaiodobenzylguanidine scintigraphy of medullary carcinoma of the thyroid.
    Skowsky WR, Wilf LH.
    South Med J; 1991 May; 84(5):636-41. PubMed ID: 1852077
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma.
    Hoefnagel CA, Delprat CC, Zanin D, van der Schoot JB.
    Clin Nucl Med; 1988 Mar; 13(3):159-65. PubMed ID: 2838213
    [Abstract] [Full Text] [Related]

  • 12. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
    Clarke SE, Lazarus CR, Wraight P, Sampson C, Maisey MN.
    J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Detection of metastatic medullary thyroid cancer with 131I-MIBG scans in Sipple's syndrome.
    Itoh H, Sugie K, Toyooka S, Kawase M, Mukaino S, Hazama F, Endo K, Torizuka K, Nakao K, Imura H.
    Eur J Nucl Med; 1986 Jan; 11(12):502-4. PubMed ID: 2874028
    [Abstract] [Full Text] [Related]

  • 15. Imaging of metastatic medullary carcinoma of the thyroid with 131I-meta-iodobenzyl guanidine.
    Poston GJ, Thomas AM, Macdonald DW, Karvounaris D, Henderson BL, George P, Lynn JA, Lavender JP.
    Nucl Med Commun; 1986 Apr; 7(4):215-21. PubMed ID: 2873544
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic and therapeutic potential of new radiopharmaceutical agents in medullary thyroid carcinoma.
    Troncone L, Rufini V, De Rosa G, Testa A.
    Henry Ford Hosp Med J; 1989 Apr; 37(3-4):178-84. PubMed ID: 2576959
    [Abstract] [Full Text] [Related]

  • 17. The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
    Verga U, Muratori F, Di Sacco G, Banfi F, Libroia A.
    Henry Ford Hosp Med J; 1989 Apr; 37(3-4):175-7. PubMed ID: 2576958
    [Abstract] [Full Text] [Related]

  • 18. [The diagnosis of thyroid carcinoma].
    Sandrock D, Munz DL.
    Dtsch Med Wochenschr; 1991 Jan 11; 116(2):77-8. PubMed ID: 1985815
    [No Abstract] [Full Text] [Related]

  • 19. Radioiodinated meta-iodobenzylguanidine uptake in medullary thyroid cancer. A French cooperative study.
    Baulieu JL, Guilloteau D, Delisle MJ, Perdrisot R, Gardet P, Delépine N, Baulieu F, Dupont JL, Talbot JN, Coutris G.
    Cancer; 1987 Nov 01; 60(9):2189-94. PubMed ID: 2894239
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.